Updated:
Silfurberg
Silfurberg was established in 2002 by Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir. The founders built the capital base through Omega Farma and Invent...
Silfurberg
Silfurberg was established in 2002 by Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir. The founders built the capital base through Omega Farma and Invent Farma, which they sold in 2016 to Apax Partners. The firm targets early-stage healthcare, biotechnology and life-science companies. It has backed Axelyf in seed rounds with Brunnur Ventures and participated in Oculis Series C financing in May 2021 with Bay City Capital, Novartis Venture Fund and others. Geographic reach centers on the Nordics and other European markets. Investment structures include direct equity and co-investments alongside specialist venture funds. Team size and current AUM remain undisclosed. The firm maintains the Silfurberg Art Fund and supports cultural initiatives including the Buffalo AKG Nordic Art and Culture Initiative and Harpa Concert Hall. Áshildur Friðriksdóttir serves as CEO of subsidiary Berg Energy Ventures while pursuing a Stanford PhD.
General information
Firm type
Multi Family Office
Year founded
2002
AUM
Undisclosed
Location
Region
Europe
Country
Iceland
City
Reykjavik
Corporate office
Suðurgata 22, 101 Reykjavík, Iceland
Principals
Friðrik Steinn Kristjánsson
Founder / Owner
Ingibjörg Jónsdóttir
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Silfurberg?
Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir retain ownership and oversight. No additional investment committee members are named publicly.
Does Silfurberg participate in fund commitments or only direct deals?
The firm makes direct investments and co-invests alongside external venture funds in early-stage rounds.
What investment stages does Silfurberg typically target?
The firm focuses on early-stage opportunities in healthcare and biotechnology.
Where does the underlying wealth come from?
Wealth originated from Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir through the creation and sale of generics companies Omega Farma and Invent Farma.
How is Silfurberg related to Framtakssjóður Íslands?
Framtakssjóður Íslands co-invested with Silfurberg in Invent Farma prior to its 2016 sale.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: